“HM was invaluable in helping secure FDA approval for our urologic device products. Their support included helping strategize negotiations with a strategic investor, advising on operational efficiencies and team communication, and leveraging their clinical network and distribution channels to access the massive Chinese market. HM’s contributions have made a huge difference for us.”

David Perry, CEO

“HM has played a crucial role in providing financial and operational support at the most opportune times for OncoImmune and OncoC4. We greatly value HM as an investor and trusted partner in both OncoImmune and OncoC4."

Dr. Yang Liu, Founder and CEO

“HM Venture Partners has been an outstanding partner for Osteal. Their support both financial and operational has been critical to successfully achieving our goals over the last 18 months. We look forward to a highly productive ongoing partnership as we enter our next phase of growth.”

David Thompson, CEO

“We rate HM as an extraordinary investor. They guided Coherent through a tough bear market in securing enough funding to continue our global clinical trials, providing access to highly relevant industry experts, and making introductions to valuable clinical trial sites and potential collaborations with global business partners. We look forward to their ongoing leadership and guidance for Coherent’s success.”.

Dr. Robert Huang, Founder and CEO